Global Gene Therapy for Inherited Genetic Disorders Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 96
Published Date: 02 Jan 2024
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Gene Therapy for Inherited Genetic Disorders market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
In the medicine field gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.A genetic disorder is a genetic problem caused by one or more abnormalities formed in the genome.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Gene Therapy for Inherited Genetic Disorders industry chain, the market status of Hospital (Eye Disorders, Hematological Disorders), Clinic (Eye Disorders, Hematological Disorders), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gene Therapy for Inherited Genetic Disorders.
Regionally, the report analyzes the Gene Therapy for Inherited Genetic Disorders markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gene Therapy for Inherited Genetic Disorders market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Gene Therapy for Inherited Genetic Disorders market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gene Therapy for Inherited Genetic Disorders industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Eye Disorders, Hematological Disorders).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gene Therapy for Inherited Genetic Disorders market.
Regional Analysis: The report involves examining the Gene Therapy for Inherited Genetic Disorders market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gene Therapy for Inherited Genetic Disorders market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Gene Therapy for Inherited Genetic Disorders:
Company Analysis: Report covers individual Gene Therapy for Inherited Genetic Disorders players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gene Therapy for Inherited Genetic Disorders This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Gene Therapy for Inherited Genetic Disorders. It assesses the current state, advancements, and potential future developments in Gene Therapy for Inherited Genetic Disorders areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gene Therapy for Inherited Genetic Disorders market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Gene Therapy for Inherited Genetic Disorders market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Eye Disorders
Hematological Disorders
Central Nervous System Disorders
Muscular Disorders
Others
Market segment by Application
Hospital
Clinic
Research Institute
Others
Market segment by players, this report covers
BioMarin Pharmaceutical Inc.
bluebird bio Inc.
Novartis AG
Orchard Therapeutics Plc
Spark Therapeutics Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gene Therapy for Inherited Genetic Disorders product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene Therapy for Inherited Genetic Disorders, with revenue, gross margin and global market share of Gene Therapy for Inherited Genetic Disorders from 2019 to 2024.
Chapter 3, the Gene Therapy for Inherited Genetic Disorders competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Gene Therapy for Inherited Genetic Disorders market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Therapy for Inherited Genetic Disorders.
Chapter 13, to describe Gene Therapy for Inherited Genetic Disorders research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Gene Therapy for Inherited Genetic Disorders
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Gene Therapy for Inherited Genetic Disorders by Type
1.3.1 Overview: Global Gene Therapy for Inherited Genetic Disorders Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Type in 2023
1.3.3 Eye Disorders
1.3.4 Hematological Disorders
1.3.5 Central Nervous System Disorders
1.3.6 Muscular Disorders
1.3.7 Others
1.4 Global Gene Therapy for Inherited Genetic Disorders Market by Application
1.4.1 Overview: Global Gene Therapy for Inherited Genetic Disorders Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Research Institute
1.4.5 Others
1.5 Global Gene Therapy for Inherited Genetic Disorders Market Size & Forecast
1.6 Global Gene Therapy for Inherited Genetic Disorders Market Size and Forecast by Region
1.6.1 Global Gene Therapy for Inherited Genetic Disorders Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Gene Therapy for Inherited Genetic Disorders Market Size by Region, (2019-2030)
1.6.3 North America Gene Therapy for Inherited Genetic Disorders Market Size and Prospect (2019-2030)
1.6.4 Europe Gene Therapy for Inherited Genetic Disorders Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size and Prospect (2019-2030)
1.6.6 South America Gene Therapy for Inherited Genetic Disorders Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Gene Therapy for Inherited Genetic Disorders Market Size and Prospect (2019-2030)
2.1 BioMarin Pharmaceutical Inc.
2.1.1 BioMarin Pharmaceutical Inc. Details
2.1.2 BioMarin Pharmaceutical Inc. Major Business
2.1.3 BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Product and Solutions
2.1.4 BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 BioMarin Pharmaceutical Inc. Recent Developments and Future Plans
2.2 bluebird bio Inc.
2.2.1 bluebird bio Inc. Details
2.2.2 bluebird bio Inc. Major Business
2.2.3 bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Product and Solutions
2.2.4 bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 bluebird bio Inc. Recent Developments and Future Plans
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business
2.3.3 Novartis AG Gene Therapy for Inherited Genetic Disorders Product and Solutions
2.3.4 Novartis AG Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Novartis AG Recent Developments and Future Plans
2.4 Orchard Therapeutics Plc
2.4.1 Orchard Therapeutics Plc Details
2.4.2 Orchard Therapeutics Plc Major Business
2.4.3 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Product and Solutions
2.4.4 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Orchard Therapeutics Plc Recent Developments and Future Plans
2.5 Spark Therapeutics Inc.
2.5.1 Spark Therapeutics Inc. Details
2.5.2 Spark Therapeutics Inc. Major Business
2.5.3 Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Product and Solutions
2.5.4 Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Spark Therapeutics Inc. Recent Developments and Future Plans
3.1 Global Gene Therapy for Inherited Genetic Disorders Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Gene Therapy for Inherited Genetic Disorders by Company Revenue
3.2.2 Top 3 Gene Therapy for Inherited Genetic Disorders Players Market Share in 2023
3.2.3 Top 6 Gene Therapy for Inherited Genetic Disorders Players Market Share in 2023
3.3 Gene Therapy for Inherited Genetic Disorders Market: Overall Company Footprint Analysis
3.3.1 Gene Therapy for Inherited Genetic Disorders Market: Region Footprint
3.3.2 Gene Therapy for Inherited Genetic Disorders Market: Company Product Type Footprint
3.3.3 Gene Therapy for Inherited Genetic Disorders Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Gene Therapy for Inherited Genetic Disorders Consumption Value and Market Share by Type (2019-2024)
4.2 Global Gene Therapy for Inherited Genetic Disorders Market Forecast by Type (2025-2030)
5.1 Global Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Application (2019-2024)
5.2 Global Gene Therapy for Inherited Genetic Disorders Market Forecast by Application (2025-2030)
6.1 North America Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2019-2030)
6.2 North America Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2019-2030)
6.3 North America Gene Therapy for Inherited Genetic Disorders Market Size by Country
6.3.1 North America Gene Therapy for Inherited Genetic Disorders Consumption Value by Country (2019-2030)
6.3.2 United States Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2019-2030)
6.3.3 Canada Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2019-2030)
6.3.4 Mexico Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2019-2030)
7.1 Europe Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2019-2030)
7.2 Europe Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2019-2030)
7.3 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country
7.3.1 Europe Gene Therapy for Inherited Genetic Disorders Consumption Value by Country (2019-2030)
7.3.2 Germany Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2019-2030)
7.3.3 France Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2019-2030)
7.3.5 Russia Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2019-2030)
7.3.6 Italy Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2019-2030)
8.1 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Region
8.3.1 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value by Region (2019-2030)
8.3.2 China Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2019-2030)
8.3.3 Japan Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2019-2030)
8.3.4 South Korea Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2019-2030)
8.3.5 India Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2019-2030)
8.3.7 Australia Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2019-2030)
9.1 South America Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2019-2030)
9.2 South America Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2019-2030)
9.3 South America Gene Therapy for Inherited Genetic Disorders Market Size by Country
9.3.1 South America Gene Therapy for Inherited Genetic Disorders Consumption Value by Country (2019-2030)
9.3.2 Brazil Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2019-2030)
9.3.3 Argentina Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2019-2030)
10.1 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Country
10.3.1 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Consumption Value by Country (2019-2030)
10.3.2 Turkey Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2019-2030)
10.3.4 UAE Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2019-2030)
11.1 Gene Therapy for Inherited Genetic Disorders Market Drivers
11.2 Gene Therapy for Inherited Genetic Disorders Market Restraints
11.3 Gene Therapy for Inherited Genetic Disorders Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 Gene Therapy for Inherited Genetic Disorders Industry Chain
12.2 Gene Therapy for Inherited Genetic Disorders Upstream Analysis
12.3 Gene Therapy for Inherited Genetic Disorders Midstream Analysis
12.4 Gene Therapy for Inherited Genetic Disorders Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Gene Therapy for Inherited Genetic Disorders Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Gene Therapy for Inherited Genetic Disorders Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Gene Therapy for Inherited Genetic Disorders Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Gene Therapy for Inherited Genetic Disorders Consumption Value by Region (2025-2030) & (USD Million)
Table 5. BioMarin Pharmaceutical Inc. Company Information, Head Office, and Major Competitors
Table 6. BioMarin Pharmaceutical Inc. Major Business
Table 7. BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Product and Solutions
Table 8. BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. BioMarin Pharmaceutical Inc. Recent Developments and Future Plans
Table 10. bluebird bio Inc. Company Information, Head Office, and Major Competitors
Table 11. bluebird bio Inc. Major Business
Table 12. bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Product and Solutions
Table 13. bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. bluebird bio Inc. Recent Developments and Future Plans
Table 15. Novartis AG Company Information, Head Office, and Major Competitors
Table 16. Novartis AG Major Business
Table 17. Novartis AG Gene Therapy for Inherited Genetic Disorders Product and Solutions
Table 18. Novartis AG Gene Therapy for Inherited Genetic Disorders Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Novartis AG Recent Developments and Future Plans
Table 20. Orchard Therapeutics Plc Company Information, Head Office, and Major Competitors
Table 21. Orchard Therapeutics Plc Major Business
Table 22. Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Product and Solutions
Table 23. Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Orchard Therapeutics Plc Recent Developments and Future Plans
Table 25. Spark Therapeutics Inc. Company Information, Head Office, and Major Competitors
Table 26. Spark Therapeutics Inc. Major Business
Table 27. Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Product and Solutions
Table 28. Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Spark Therapeutics Inc. Recent Developments and Future Plans
Table 30. Global Gene Therapy for Inherited Genetic Disorders Revenue (USD Million) by Players (2019-2024)
Table 31. Global Gene Therapy for Inherited Genetic Disorders Revenue Share by Players (2019-2024)
Table 32. Breakdown of Gene Therapy for Inherited Genetic Disorders by Company Type (Tier 1, Tier 2, and Tier 3)
Table 33. Market Position of Players in Gene Therapy for Inherited Genetic Disorders, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 34. Head Office of Key Gene Therapy for Inherited Genetic Disorders Players
Table 35. Gene Therapy for Inherited Genetic Disorders Market: Company Product Type Footprint
Table 36. Gene Therapy for Inherited Genetic Disorders Market: Company Product Application Footprint
Table 37. Gene Therapy for Inherited Genetic Disorders New Market Entrants and Barriers to Market Entry
Table 38. Gene Therapy for Inherited Genetic Disorders Mergers, Acquisition, Agreements, and Collaborations
Table 39. Global Gene Therapy for Inherited Genetic Disorders Consumption Value (USD Million) by Type (2019-2024)
Table 40. Global Gene Therapy for Inherited Genetic Disorders Consumption Value Share by Type (2019-2024)
Table 41. Global Gene Therapy for Inherited Genetic Disorders Consumption Value Forecast by Type (2025-2030)
Table 42. Global Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2019-2024)
Table 43. Global Gene Therapy for Inherited Genetic Disorders Consumption Value Forecast by Application (2025-2030)
Table 44. North America Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2019-2024) & (USD Million)
Table 45. North America Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2025-2030) & (USD Million)
Table 46. North America Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2019-2024) & (USD Million)
Table 47. North America Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2025-2030) & (USD Million)
Table 48. North America Gene Therapy for Inherited Genetic Disorders Consumption Value by Country (2019-2024) & (USD Million)
Table 49. North America Gene Therapy for Inherited Genetic Disorders Consumption Value by Country (2025-2030) & (USD Million)
Table 50. Europe Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2019-2024) & (USD Million)
Table 51. Europe Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2025-2030) & (USD Million)
Table 52. Europe Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2019-2024) & (USD Million)
Table 53. Europe Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2025-2030) & (USD Million)
Table 54. Europe Gene Therapy for Inherited Genetic Disorders Consumption Value by Country (2019-2024) & (USD Million)
Table 55. Europe Gene Therapy for Inherited Genetic Disorders Consumption Value by Country (2025-2030) & (USD Million)
Table 56. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2019-2024) & (USD Million)
Table 57. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2025-2030) & (USD Million)
Table 58. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2019-2024) & (USD Million)
Table 59. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2025-2030) & (USD Million)
Table 60. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value by Region (2019-2024) & (USD Million)
Table 61. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value by Region (2025-2030) & (USD Million)
Table 62. South America Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2019-2024) & (USD Million)
Table 63. South America Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2025-2030) & (USD Million)
Table 64. South America Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2019-2024) & (USD Million)
Table 65. South America Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2025-2030) & (USD Million)
Table 66. South America Gene Therapy for Inherited Genetic Disorders Consumption Value by Country (2019-2024) & (USD Million)
Table 67. South America Gene Therapy for Inherited Genetic Disorders Consumption Value by Country (2025-2030) & (USD Million)
Table 68. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2019-2024) & (USD Million)
Table 69. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2025-2030) & (USD Million)
Table 70. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2019-2024) & (USD Million)
Table 71. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2025-2030) & (USD Million)
Table 72. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Consumption Value by Country (2019-2024) & (USD Million)
Table 73. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Consumption Value by Country (2025-2030) & (USD Million)
Table 74. Gene Therapy for Inherited Genetic Disorders Raw Material
Table 75. Key Suppliers of Gene Therapy for Inherited Genetic Disorders Raw Materials
List of Figures
Figure 1. Gene Therapy for Inherited Genetic Disorders Picture
Figure 2. Global Gene Therapy for Inherited Genetic Disorders Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Type in 2023
Figure 4. Eye Disorders
Figure 5. Hematological Disorders
Figure 6. Central Nervous System Disorders
Figure 7. Muscular Disorders
Figure 8. Others
Figure 9. Global Gene Therapy for Inherited Genetic Disorders Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 10. Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Application in 2023
Figure 11. Hospital Picture
Figure 12. Clinic Picture
Figure 13. Research Institute Picture
Figure 14. Others Picture
Figure 15. Global Gene Therapy for Inherited Genetic Disorders Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global Gene Therapy for Inherited Genetic Disorders Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global Market Gene Therapy for Inherited Genetic Disorders Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 18. Global Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Region (2019-2030)
Figure 19. Global Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Region in 2023
Figure 20. North America Gene Therapy for Inherited Genetic Disorders Consumption Value (2019-2030) & (USD Million)
Figure 21. Europe Gene Therapy for Inherited Genetic Disorders Consumption Value (2019-2030) & (USD Million)
Figure 22. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value (2019-2030) & (USD Million)
Figure 23. South America Gene Therapy for Inherited Genetic Disorders Consumption Value (2019-2030) & (USD Million)
Figure 24. Middle East and Africa Gene Therapy for Inherited Genetic Disorders Consumption Value (2019-2030) & (USD Million)
Figure 25. Global Gene Therapy for Inherited Genetic Disorders Revenue Share by Players in 2023
Figure 26. Gene Therapy for Inherited Genetic Disorders Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 27. Global Top 3 Players Gene Therapy for Inherited Genetic Disorders Market Share in 2023
Figure 28. Global Top 6 Players Gene Therapy for Inherited Genetic Disorders Market Share in 2023
Figure 29. Global Gene Therapy for Inherited Genetic Disorders Consumption Value Share by Type (2019-2024)
Figure 30. Global Gene Therapy for Inherited Genetic Disorders Market Share Forecast by Type (2025-2030)
Figure 31. Global Gene Therapy for Inherited Genetic Disorders Consumption Value Share by Application (2019-2024)
Figure 32. Global Gene Therapy for Inherited Genetic Disorders Market Share Forecast by Application (2025-2030)
Figure 33. North America Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Type (2019-2030)
Figure 34. North America Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Application (2019-2030)
Figure 35. North America Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Gene Therapy for Inherited Genetic Disorders Consumption Value (2019-2030) & (USD Million)
Figure 37. Canada Gene Therapy for Inherited Genetic Disorders Consumption Value (2019-2030) & (USD Million)
Figure 38. Mexico Gene Therapy for Inherited Genetic Disorders Consumption Value (2019-2030) & (USD Million)
Figure 39. Europe Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Type (2019-2030)
Figure 40. Europe Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Application (2019-2030)
Figure 41. Europe Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Country (2019-2030)
Figure 42. Germany Gene Therapy for Inherited Genetic Disorders Consumption Value (2019-2030) & (USD Million)
Figure 43. France Gene Therapy for Inherited Genetic Disorders Consumption Value (2019-2030) & (USD Million)
Figure 44. United Kingdom Gene Therapy for Inherited Genetic Disorders Consumption Value (2019-2030) & (USD Million)
Figure 45. Russia Gene Therapy for Inherited Genetic Disorders Consumption Value (2019-2030) & (USD Million)
Figure 46. Italy Gene Therapy for Inherited Genetic Disorders Consumption Value (2019-2030) & (USD Million)
Figure 47. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Type (2019-2030)
Figure 48. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Application (2019-2030)
Figure 49. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Region (2019-2030)
Figure 50. China Gene Therapy for Inherited Genetic Disorders Consumption Value (2019-2030) & (USD Million)
Figure 51. Japan Gene Therapy for Inherited Genetic Disorders Consumption Value (2019-2030) & (USD Million)
Figure 52. South Korea Gene Therapy for Inherited Genetic Disorders Consumption Value (2019-2030) & (USD Million)
Figure 53. India Gene Therapy for Inherited Genetic Disorders Consumption Value (2019-2030) & (USD Million)
Figure 54. Southeast Asia Gene Therapy for Inherited Genetic Disorders Consumption Value (2019-2030) & (USD Million)
Figure 55. Australia Gene Therapy for Inherited Genetic Disorders Consumption Value (2019-2030) & (USD Million)
Figure 56. South America Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Type (2019-2030)
Figure 57. South America Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Application (2019-2030)
Figure 58. South America Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Country (2019-2030)
Figure 59. Brazil Gene Therapy for Inherited Genetic Disorders Consumption Value (2019-2030) & (USD Million)
Figure 60. Argentina Gene Therapy for Inherited Genetic Disorders Consumption Value (2019-2030) & (USD Million)
Figure 61. Middle East and Africa Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Type (2019-2030)
Figure 62. Middle East and Africa Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Application (2019-2030)
Figure 63. Middle East and Africa Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Country (2019-2030)
Figure 64. Turkey Gene Therapy for Inherited Genetic Disorders Consumption Value (2019-2030) & (USD Million)
Figure 65. Saudi Arabia Gene Therapy for Inherited Genetic Disorders Consumption Value (2019-2030) & (USD Million)
Figure 66. UAE Gene Therapy for Inherited Genetic Disorders Consumption Value (2019-2030) & (USD Million)
Figure 67. Gene Therapy for Inherited Genetic Disorders Market Drivers
Figure 68. Gene Therapy for Inherited Genetic Disorders Market Restraints
Figure 69. Gene Therapy for Inherited Genetic Disorders Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of Gene Therapy for Inherited Genetic Disorders in 2023
Figure 72. Manufacturing Process Analysis of Gene Therapy for Inherited Genetic Disorders
Figure 73. Gene Therapy for Inherited Genetic Disorders Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
BioMarin Pharmaceutical Inc. bluebird bio Inc. Novartis AG Orchard Therapeutics Plc Spark Therapeutics Inc.
Related Reports
19 Jan 2023
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
